Paying users zone. Data is hidden behind: .
Get 1-month access to Regeneron Pharmaceuticals Inc. for $15.99, or
get full access to the entire website for at least 3 months from $49.99.
This is a one-time payment. There is no automatic renewal.
Regeneron Pharmaceuticals Inc. pages available today for free:
Common-Size Income Statement
Regeneron Pharmaceuticals Inc., common-size consolidated income statement
|Income statement item||Description||The company|
|Income from operations||The net result for the period of deducting operating expenses from operating revenues.||Regeneron Pharmaceuticals Inc.’s income from operations as a percentage of revenues increased from 2017 to 2018 but then decreased significantly from 2018 to 2019.|
|Income before income taxes||Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.||Regeneron Pharmaceuticals Inc.’s income before income taxes as a percentage of revenues increased from 2017 to 2018 but then decreased significantly from 2018 to 2019.|
|Net income||The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.||Regeneron Pharmaceuticals Inc.’s net income as a percentage of revenues increased from 2017 to 2018 but then slightly decreased from 2018 to 2019 not reaching 2017 level.|